Commenters also stated that the MS-DRG relative weights could be distorted by a lag between when a hospital updates its price transparency data and when it submits its cost report
In April 2026 the FDA removed BPC-157 along with a number of other peptides, TB-500 among them from the Section 503A Category 2 list that had restricted compounding, and a Pharmacy Compounding Advisory Committee meeting on 2324 July 2026 is due to consider them further
The FDA's April 2026 announcement to remove injectable GHK-Cu from the Category 2 restricted list is significant here
Asian Pac J Cancer Prev 25:33933411
Similarly, rats given BPC-157 helped with knee osteoarthritis
A single-item literacy screener was included to evaluate health literacy 17 (How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy?) and there was a single-item measure of health status 18 (How would you rate your overall health?)